Search Results for: recommended

Weekly reads: freeze-dried cloning, FDA signals, stem cell escapees

July 9, 2022 / By / 1 Comment
Human-cloning

Cloning is one of those topics that both fascinates and kind of scares people, especially the idea of duplicating people. I regularly cover the topic here on The Niche because stem cell technologies are involved. Also, one form of the process sometimes called “therapeutic cloning” involves embryonic stem cells. Duplicating mammals has now long been …

Weekly reads: freeze-dried cloning, FDA signals, stem cell escapees Read More »

Weekly reads: NIH grants, side effect of darker hair, FDA warning, CRISPR

July 2, 2022 / By / Leave a Comment
Grant writers handbook, grants cartoon

The last six months I’ve been spending even more time than usual writing NIH grants (and a few others). The last two weeks have been especially busy on this front as I am getting an R01 renewal out the door. My paper reading lately has been mostly related to the grant writing I’m doing. Still, …

Weekly reads: NIH grants, side effect of darker hair, FDA warning, CRISPR Read More »

Weekly reads: teratoma in iPSC trial, Piero Anversa & friends, Athersys, China Initiative

June 25, 2022 / By / 1 Comment
Dr-Piero-Anversa

It’s been mostly a downbeat week on the stem cell news front including a deep revisit by Reuters to the Piero Anversa case that has new revelations. It’s ugly stuff involving other folks too. We’ll start on the iPS cell front, where a trial participant had a teratoma. I’ve had a long-standing interest in the …

Weekly reads: teratoma in iPSC trial, Piero Anversa & friends, Athersys, China Initiative Read More »

Weekly reads: Jan Nolta recognition, new director after Irv, FDA guidance

June 19, 2022 / By / 2 Comments
Dr. Jan Nolta UC Davis

People are the real driving force in the stem cell and regenerative medicine field including my colleague Jan Nolta here at UC Davis. She is the Director of our Stem Cell Program. There’s also news about Stanford’s stem cell Director Irv Weissman. Jan Nolta receives award Jan’s lab is prolific and in many ways is …

Weekly reads: Jan Nolta recognition, new director after Irv, FDA guidance Read More »

Weekly stem cell reads: parabiosis, UC Davis trial, HeLa lawsuit, gray hair

May 28, 2022 / By / 3 Comments
Parabiosis, anti-aging

Parabiosis refers to the joining together of two animals, typically rodents in research. They become one interconnected living system that shares blood. Research on mouse parabiosis has sparked much interest in anti-aging therapies. These might utilize “young” materials to help older people. Our first recommended read is a parabiosis paper. Before we jump into that, …

Weekly stem cell reads: parabiosis, UC Davis trial, HeLa lawsuit, gray hair Read More »

Weekly reads: our new brain tumor paper, levitation, dear doctor, Japan, more

May 21, 2022 / By / Leave a Comment
brain tumor, H3.3 K27M, ASCL1

There’s nothing quite like getting a new paper out as a scientist running a research lab so this week we can celebrate our new pediatric brain tumor study. I’ll start the weekly reads with that paper. Of course, getting new grants is amazing too but there’s more of a feel of completion after a paper …

Weekly reads: our new brain tumor paper, levitation, dear doctor, Japan, more Read More »

Weekly reads: neural stem cells, CRISPR brain, Vertex, cytoplasm surprise

May 14, 2022 / By / Leave a Comment
neural stem cells

Some people consider the brain to be equivalent to a living computer and in that sense it’s too bad that computers don’t have the equal of neural stem cells to help them fix themselves. Is the internet one big neural network-like web? There was a quake in the stem cell internet as CIRM’s main website …

Weekly reads: neural stem cells, CRISPR brain, Vertex, cytoplasm surprise Read More »

Weekly science reads: Macchiarini trial, somites, CRISPR babies

April 30, 2022 / By / Leave a Comment
organoids with somites, cool science

This has been one of those weeks where I spent some time thinking about taking risks in science. How much risk one should take? Risks can come in many forms. It could be at the core level at the bench doing specific experiments and not others. There’s risk in clinical trials, and even in advocacy. Sometimes …

Weekly science reads: Macchiarini trial, somites, CRISPR babies Read More »

Weekly reads: fibroblasts, cancer stem cells, Parkinson’s

April 23, 2022 / By / Leave a Comment
fibroblasts stained

It seems like the field of cell biology has mixed feelings about fibroblasts so I’m going to start off there with the recommended reads. But first, check out our stem cell YouTube channel as we are steadily heading toward 500 subscribers and 30,000 views. Please subscribe. I’ve pasted one of our top videos below, which …

Weekly reads: fibroblasts, cancer stem cells, Parkinson’s Read More »

Recommend reads: CRISPR baby guy free, DNMT3, sperm, Editas, hearing loss, reprogramming

April 17, 2022 / By / 3 Comments
Dura et al sperm development

We often don’t think of them that way but reproductive cells like sperm and egg are also relatives of stem cells, and it turns out that there are stem cells that make the reproductive cells too like sperm stem cells. Sperm and germ cell stem cells DNMT3A-dependent DNA methylation is required for spermatogonial stem cells …

Recommend reads: CRISPR baby guy free, DNMT3, sperm, Editas, hearing loss, reprogramming Read More »